Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: The Toronto experience with the Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial

Journal of Clinical Oncology

Volumn 24, Issue 25, 2006, Pages 4158-4162

  Wallace, Kris ^a   Fleshner, Neil ^a   Jewett, Michael ^a   Basiuk, Joan ^a   Crook, Juanita ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; CANADA; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; AGED; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; PROSTATE TUMOR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

AGED; BRACHYTHERAPY; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; ONTARIO; PATIENT EDUCATION; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS;

EID: 33748673324     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.3875     Document Type: Article

References (23)

1. Davis JW, Kuban DA, Lynch DF, et al: Quality of life after treatment for localized prostate cancer: Differences based on treatment modality. J Urol 166:947-952, 2001
2. Stone NN, Stock RG: Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate. Urol Clin North Am 30:351-362, 2003
3. Bacon CG, Giovannucci E, Testa M, et al: The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 166:1804-1810, 2001
4. Lee WR, Hall MC, McQuellan RP, et al: A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 51:614-623, 2001
5. Wei JT, Dunn RL, Sandler HM, et al: Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20:557-566, 2002
6. Verheggen FW, Nieman F, Jonkers R: Determinants of patient participation in clinical studies requiring informed consent: Why patients enter a clinical trial. Patient Educ Couns 35:111-125, 1998
7. Jenkins V, Fallowfield L: Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. Br J Cancer 82:1783-1788, 2000
8. Chard JA, Lilford RJ: The use of equipoise in clinical trials. Soc Sci Med 47:891-898, 1998
9. Mills N, et al: Perceptions of equipoise are crucial to trial participation: A qualitative study of men in the ProtecT study. Control Clin Trials 24:272-282, 2003
10. Movsas B, Moughan J, Owen J, et al: Who enrolls onto clinical oncology trials? A patterns of care study analysis. Int J Radiat Oncol Biol Phys 57:S214, 2003 (suppl 2)
11. Sanchez S, Salazar G, Tijero M, et al.: Informed consent procedures: Responsibilities of researchers in developing countries. Bioethics 15:398-412, 2001
12. Henzlova MJ, Blackburn GH, Bradley EJ, et al: Patient perception of a long-term clinical trial: Experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial - SOLVD Close-Out Working Group. Control Clin Trials 15:284-293, 1994
13. Bevan EG, Chee LC, McGhee SM, et al: Patients' attitudes to participation in clinical trials. Br J Clin Pharmacol 35:204-207, 1993
14. Llewellyn-Thomas HA, Thiel EC, Sem FW, et al: Presenting clinical trial information: A comparison of methods. Patient Educ Couns 25:97-107, 1995
15. Ellis PM: Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature. Ann Oncol 11:939-945, 2000
16. Catt S, Fallowfield L, Jenkins V, et al: The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK. Br J Cancer 93:1092-1097, 2005
17. Hunter CP, Frelick RW, Feldman AR, et al: Selection factors in clinical trials: Results from the Community Clinical Oncology Program Physician's Patient Log. Cancer Treat Rep 71:559-565, 1987
18. Ellis PM, Butow PN, Tattersall MH, et al: Randomized clinical trials in oncology: Understanding and attitudes predict willingness to participate. J Clin Oncol 19:3554-3561, 2001
19. Fallowfield L: Can we improve the professional and personal fulfillment of doctors in cancer medicine? Br J Cancer 71:1132-1133, 1995
20. Benson AB 3rd, Pregler JP, Bean JA, et al: Oncologists' reluctance to accrue patients onto clinical trials: An Illinois Cancer Center study. J Clin Oncol 9:2067-2075, 1991
21. Fisher B: Clinical trials for the evaluation of cancer therapy. Cancer 54:2609-2617, 1984 (suppl 11)
22. Mast H, Chambless LE, Mohr JP, et al: Indications for endarterectomy in asymptomatic stenoses of the internal or common carotid artery: Results of the North American ACAS Study [in German]. Zentralbl Chir 121:1033-1035, 1996
23. Gorelick PB, Harris Y, Burnett B, et al: The recruitment triangle: Reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial: An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS). J Natl Med Assoc 90:141-145, 1998